Pure Global
NCT06385184

Social & QoL Behaviors in Parkinson's Disease

Social Behaviors and Quality of Life in Individuals With Parkinson's Disease
Gregory Wallace·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Parkinson Disease
Drug/Device/Intervention
No Intervention
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Gregory Wallace
Funder
George Washington University
Location
Washington, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 08, 2024
End date
Dec 31, 2025
Enrollment
500 participants
Primary outcome

Subjective Quality of Life,Social Behavior,Activities of Daily Living,Mental Health,Cognition

Summary

Adults with Parkinson's Disease experience an array of challenges and changes in daily
 living, behaviors, and functioning throughout the progression of their condition. The
 investigators want to learn more about the effects of Parkinson's Disease on individuals'
 social behavior and quality of life (QoL) compared to people of the same age without
 Parkinson's Disease.

ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismSecondary parkinsonism, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06385184
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06385184 through Pure Global AI's free database. This phase not specified trial is sponsored by Gregory Wallace and is currently Recruiting. The study focuses on Parkinson Disease. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.